Health & Wellness Today New York
SEE OTHER BRANDS

Get your fresh news on health and wellness in New York

Health & Wellness Today New York: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health & Wellness Today New York.

Press releases published on May 20, 2025

Samuel Waxman Cancer Research Foundation Held 11th Annual Luncheon 2025

Samuel Waxman Cancer Research Foundation Held 11th Annual Luncheon 2025

Luncheon Honored Susan Pernick and AKRIS Held a Live Fashion Presentation of their Spring/Summer 2025 collection NEW YORK, NY, UNITED STATES, May 20, 2025 /⁨EINPresswire.com⁩/ -- The 11th Annual Waxman Luncheon, benefiting the Samuel Waxman Cancer …

Advancing Macrophage Research with iPSC Technology: Creative Biolabs Leads the Way

Advancing Macrophage Research with iPSC Technology: Creative Biolabs Leads the Way

With its wealth of experience, Creative Biolabs stands ready to support global researchers in advancing their iPSC-derived cell therapy studies. SHIRLEY, NY, UNITED STATES, May 20, 2025 /⁨EINPresswire.com⁩/ -- In the rapidly expanding field of …

White Plains Hospital Teams with Layer Health to Streamline Clinical Registry Reporting

White Plains Hospital Teams with Layer Health to Streamline Clinical Registry Reporting

AI-Powered platform supports registry reporting, optimizes resources and enhances patient care \ WHITE PLAINS, NY, UNITED STATES, May 20, 2025 /⁨EINPresswire.com⁩/ -- White Plains Hospital and Layer Health, a leading artificial intelligence (AI) company …

Online Marketing for Doctors Delivers Exceptional Growth Results for Medical Professionals

Online Marketing for Doctors Delivers Exceptional Growth Results for Medical Professionals

Online Marketing for Doctors empowers healthcare professionals worldwide to achieve rapid, measurable growth through specialized digital strategies. Their clients report major boosts in website traffic, patient inquiries, and marketing efficiency, while …

Rick Shaw, Founder, Awareity, Talks About A Solution For Tragic, Seemingly-Unending, School Shootings, "THIS MUST STOP"

Rick Shaw, Founder, Awareity, Talks About A Solution For Tragic, Seemingly-Unending, School Shootings, "THIS MUST STOP"

Awareity’s solution, successful in OK, NE, TX, AZ, CT and others, equips communities to use almost always available “Pre-Incident Indicators” and Resources. NEW YORK, NY, UNITED STATES, May 20, 2025 /⁨EINPresswire.com⁩/ -- About Awareity We believe in …

Biohacker and 4x NY Times Bestselling Author Dave Asprey Returns with Groundbreaking New Book, Heavily Meditated

Biohacker and 4x NY Times Bestselling Author Dave Asprey Returns with Groundbreaking New Book, Heavily Meditated

The Fast Path to Remove Your Triggers, Dissolve Stress, and Activate Inner Peace NEW YORK, NY, UNITED STATES, May 20, 2025 /⁨EINPresswire.com⁩/ -- Dave Asprey, the father of biohacking and 4x New York Times bestselling author, is back with his most …

American Friends of NATAL Accepts the PowerNET '25 Award on Behalf of NATAL’s Trauma-Informed Career Development Program

American Friends of NATAL Accepts the PowerNET '25 Award on Behalf of NATAL’s Trauma-Informed Career Development Program

AFN proudly accepted The Network of Jewish Human Service Agencies PowerNET 2025 Impact Award on behalf of NATAL’s Trauma-Informed Career Development Program. NEW YORK, NY, UNITED STATES, May 20, 2025 /⁨EINPresswire.com⁩/ -- American Friends of NATAL (AFN …

Teva Announces Successful Upsizing and Pricing of $2,300,000,000 (Equivalent) Senior Notes; Proceeds to Repay Existing Debt

Teva Announces Successful Upsizing and Pricing of $2,300,000,000 (Equivalent) Senior Notes; Proceeds to Repay Existing Debt

TEL AVIV, Israel, May 20, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) (“Teva”) announced today that it successfully upsized its offering and priced approximately $2,300,000,000 (equivalent) of its senior notes (the “ …

Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SOUTH SAN FRANCISCO, Calif., May 20, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) (the “Company” or “Vaxart”) today announced that the Compensation Committee of the Board of Directors approved certain equity awards to the Company’s new Chief …

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

NOVATO, Calif., May 20, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultra-rare diseases, today reported the grant of 44 …

Segra International Acquires Klonetics to Expand Nursery Capacity and Accelerate Growth

Segra International Acquires Klonetics to Expand Nursery Capacity and Accelerate Growth

VANCOUVER, British Columbia, May 20, 2025 (GLOBE NEWSWIRE) -- Segra International (“Segra”), a global leader in cannabis agriculture technology, proudly announces its strategic amalgamation with Klonetics Plant Science Inc., a licensed cannabis nursery and …

Global Alzheimer’s Platform Foundation Applauds FDA Authorization of the First Blood-Based Diagnostic Test for Assessing Alzheimer’s Disease

Global Alzheimer’s Platform Foundation Applauds FDA Authorization of the First Blood-Based Diagnostic Test for Assessing Alzheimer’s Disease

WASHINGTON, May 20, 2025 (GLOBE NEWSWIRE) -- The Global Alzheimer’s Platform Foundation® (GAP) applauds the FDA's clearance of the first blood test to diagnose Alzheimer’s disease. Fujirebio’s Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio invitro …

TrialWire the AI and Algorithm-powered Platform Named a Fierce CRO Award Finalist in the “Outstanding Patient Recruitment and Retention” Category

TrialWire the AI and Algorithm-powered Platform Named a Fierce CRO Award Finalist in the “Outstanding Patient Recruitment and Retention” Category

SAN FRANCISCO, May 20, 2025 (GLOBE NEWSWIRE) -- TrialWire today announces it was named a Fierce CRO Award finalist by Fierce Biotech in the Outstanding Patient Recruitment and Retention category. TrialWire is the AI and algorithm-powered patient- …

Fitch Ratings Agency Upgrades Teva Rating to BB+ Recognizing Successful Execution of Its Pivot to Growth Strategy

Fitch Ratings Agency Upgrades Teva Rating to BB+ Recognizing Successful Execution of Its Pivot to Growth Strategy

TEL AVIV, Israel, May 20, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals (NYSE and TASE: TEVA) today announced that Fitch Ratings Agency (“Fitch”) has raised the Company's corporate credit rating to BB+, with a stable outlook; from BB. Fitch's report cites …

Neuphoria Provides First Quarter 2025 Business Updates

Neuphoria Provides First Quarter 2025 Business Updates

Cash runway into Q3 2026 AFFIRM-1 Phase 3 clinical trial of BNC-210 in social anxiety disorder on track for topline readout in Q3 2025 α7 nicotinic acetylcholine receptor PAM MK-1167 partnered with Merck and in Phase 2 clinical trial in Alzheimer’s …

XWELL Reports First Quarter 2025 Results, Advancing Mission to Liberate Science-Proven Wellness

XWELL Reports First Quarter 2025 Results, Advancing Mission to Liberate Science-Proven Wellness

NEW YORK, May 20, 2025 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), a pioneer in science-proven, accessible wellness, today reported results for the first quarter ended March 31, 2025. With a growing portfolio of in-airport …

CooperCompanies’ 2024 Sustainability Report Showcases Efforts that Benefit People and the Planet

CooperCompanies’ 2024 Sustainability Report Showcases Efforts that Benefit People and the Planet

SAN RAMON, Calif., May 20, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (“Cooper”) (Nasdaq: COO), a leading medical device company, published its 2024 Sustainability Report. The report showcases the company’s initiatives to foster positive change for both …

GENFIT va recevoir un paiement d’étape de 26,5 millions d’euros à la suite de l’approbation du prix et du remboursement d’Iqirvo® par Ipsen en Italie

GENFIT va recevoir un paiement d’étape de 26,5 millions d’euros à la suite de l’approbation du prix et du remboursement d’Iqirvo® par Ipsen en Italie

Lille (France), Cambridge (Massachusetts, Etats-Unis), Zurich (Suisse), le 20 mai, 2025 – GENFIT (Nasdaq et Euronext : GNFT), société́ biopharmaceutique de stade clinique avancé engagée dans l’amélioration de la vie des patients atteints de maladies rares …

GENFIT to receive a €26.5 million milestone payment following the approval of pricing and reimbursement of Ipsen’s Iqirvo® in Italy

GENFIT to receive a €26.5 million milestone payment following the approval of pricing and reimbursement of Ipsen’s Iqirvo® in Italy

Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), May 20, 2025 – GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today …

RxSight, Inc. to Participate in the Stifel 2025 Virtual Ophthalmology Forum

RxSight, Inc. to Participate in the Stifel 2025 Virtual Ophthalmology Forum

ALISO VIEJO, Calif., May 20, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service